Non-pharmacological Analgesia During Heel Prick

This study has been terminated.
(The data showed that pain was higher for our standardized method of sampling)
Sponsor:
Information provided by (Responsible Party):
Miguel Angel Marin Gabriel, Puerta de Hierro University Hospital
ClinicalTrials.gov Identifier:
NCT01576432
First received: April 2, 2012
Last updated: April 10, 2012
Last verified: April 2012
  Purpose

Objective

To investigate the analgesic effect (measured with NIPS) of breastfeeding in addition to skin-to-skin contact versus other methods of non-pharmacological analgesia during blood sampling through heel lance in healthy term neonates. The influences of non-pharmacological methods on crying time, percentage of crying while sampling, heart rate, number of attempts and duration of sampling were studied.

Methods

Randomised controlled trial performed on 136 healthy term newborns in the maternity ward of a tertiary hospital. The inclusion criteria were: healthy term neonates, wish to breastfeed and absence of feeding during the previous 60 minutes. Neonates were randomly assigned to four groups: group 1, breastfed with skin-to-skin contact ; group 2, oral sucrose with skin-to-skin contact ; group 3, skin-to-skin contact ; or group 4, receiving oral sucrose Data for the primary objective was analysed per intention to treat. This study was approved by local ethical committee.


Condition Intervention
Pain
Breastfeeding
Behavioral: Assess pain with the NIPS score

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Caregiver)
Primary Purpose: Treatment
Official Title: Non-pharmacological Analgesia During Heel Prick: A Randomized, Controlled Trial

Resource links provided by NLM:


Further study details as provided by Puerta de Hierro University Hospital:

Primary Outcome Measures:
  • NIPS score during heel prick in healthy term neonates [ Time Frame: Midpoint analysis will be conducted when half the patients are recruited (134 subjects), at an estimated time of 12 months. ] [ Designated as safety issue: Yes ]

    The NIPS scale is a validated 6-indicator scale for the assessment of acute pain in neonates. Score ranges from 0 (no pain) to 7 (severe pain).

    NIPS score was evaluated at three time points (2 minutes before heel prick (NIPS-t0), during heel prick (NIPS-t1) and 2 minutes after heel lance (NIPS-t2))in 4 groups where different methods of non-pharmacological analgesia were applied. Results are shown as mean+-SD.

    NIPS score ≥4 means moderate-severe pain. Thus results are also shown as the % of patients with NIPS score ≥4 at different time points (t0, t1 and t2)



Secondary Outcome Measures:
  • Crying time during heel prick in healthy term neonates [ Time Frame: Midpoint analysis will be conducted when half the patients are recruited (134 subjects), at an estimated time of 12 months. ] [ Designated as safety issue: Yes ]
    Crying time (in seconds) in 4 groups where different methods of non-pharmacological analgesia were applied. The timer was started at heel prick and stopped when 5 dried spots of blood were collected on a filter paper card. Results are shown as mean+-SD.

  • Percentage of crying during heel prick in healthy term neonates [ Time Frame: Midpoint analysis will be conducted when half the patients are recruited (134 subjects), at an estimated time of 12 months. ] [ Designated as safety issue: Yes ]
    Percentage of crying in 4 groups where different methods of non-pharmacological analgesia were applied during heel prick. Percentage of crying was defined as the ratio between crying time while sampling and time of the procedure. Results are shown as mean+-SD.

  • Heart rate during heel prick in healthy term neonates [ Time Frame: Midpoint analysis will be conducted when half the patients are recruited (134 subjects), at an estimated time of 12 months. ] [ Designated as safety issue: Yes ]
    Heart rate was monitored by a pulse oximeter (Radical MasimoSet Datascope, Masimo Corporation, Irvine, CA) set on the infant's hand or foot. Hear rate was measured continuously but special attention was given to three time points: t0 (2 minutes before sampling); t1 (the highest value of the first 10 seconds after heel prick); and t2 (2 minutes after the procedure). Results are shown as Mean+-SD

  • Sampling duration during heel prick in healthy term neonates [ Time Frame: Midpoint analysis will be conducted when half the patients are recruited (134 subjects), at an estimated time of 12 months. ] [ Designated as safety issue: Yes ]
    Sampling duration (in seconds) was defined as the time spent to obtained 5 dried spots of blood collected on a filter paper card. Results are shown as mean+-SD.

  • Number of attempts during heel prick [ Time Frame: Midpoint analysis will be conducted when half the patients are recruited (134 subjects), at an estimated time of 12 months. ] [ Designated as safety issue: Yes ]
    Number of attempts need to obtaine 5 dried spots of blood collected on a filter paper card. Results are shown as % of patients with 1 attempt and % of patients with 2 attempts.


Enrollment: 136
Study Start Date: January 2011
Study Completion Date: April 2012
Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Breastfeeding + skin-to-skin contact
In group 1 (BF+SSC), neonates dressed with a diaper were held in prone, in SSC with the mother; breastfeeding (BF) was started at least 5 minutes before heel lance and maintained during sampling
Behavioral: Assess pain with the NIPS score
In group 1 (BF+SSC), neonates dressed with a diaper were held in prone, in SSC with the mother; BF was started at least 5 minutes before heel lance and maintained during sampling. In group 2 (sucrose + SSC), neonates were held in prone between the mothers' breast at least 5 minutes before sampling and 2 ml 24% sucrose was given with a sterile syringe in the mouth 2 minutes before heel lance. In group 3 (SSC), neonates were held between the mother's breast as in group 2, but no sucrose was given. In group 4 (Sucrose), 2 ml 24% sucrose was administered through a sterile syringe in the mouth 2 minutes before heel lance to neonates laid on supine on a cot; the procedure was done in the presence of the mother. Mothers were allowed to speak or touch their babies in all the groups.
Experimental: Sucrose + skin-to-skin contact
In group 2 (sucrose + SSC), neonates were held in prone between the mothers' breast at least 5 minutes before sampling and 2 ml 24% sucrose was given with a sterile syringe in the mouth 2 minutes before heel lance.
Behavioral: Assess pain with the NIPS score
In group 1 (BF+SSC), neonates dressed with a diaper were held in prone, in SSC with the mother; BF was started at least 5 minutes before heel lance and maintained during sampling. In group 2 (sucrose + SSC), neonates were held in prone between the mothers' breast at least 5 minutes before sampling and 2 ml 24% sucrose was given with a sterile syringe in the mouth 2 minutes before heel lance. In group 3 (SSC), neonates were held between the mother's breast as in group 2, but no sucrose was given. In group 4 (Sucrose), 2 ml 24% sucrose was administered through a sterile syringe in the mouth 2 minutes before heel lance to neonates laid on supine on a cot; the procedure was done in the presence of the mother. Mothers were allowed to speak or touch their babies in all the groups.
Experimental: Skin-to-skin contact
In group 3 (SSC), neonates were held between the mother's breast as in group 2, but no sucrose was given.
Behavioral: Assess pain with the NIPS score
In group 1 (BF+SSC), neonates dressed with a diaper were held in prone, in SSC with the mother; BF was started at least 5 minutes before heel lance and maintained during sampling. In group 2 (sucrose + SSC), neonates were held in prone between the mothers' breast at least 5 minutes before sampling and 2 ml 24% sucrose was given with a sterile syringe in the mouth 2 minutes before heel lance. In group 3 (SSC), neonates were held between the mother's breast as in group 2, but no sucrose was given. In group 4 (Sucrose), 2 ml 24% sucrose was administered through a sterile syringe in the mouth 2 minutes before heel lance to neonates laid on supine on a cot; the procedure was done in the presence of the mother. Mothers were allowed to speak or touch their babies in all the groups.
Active Comparator: Sucrose
In group 4 (Sucrose), 2 ml 24% sucrose was administered through a sterile syringe in the mouth 2 minutes before heel lance to neonates laid on supine on a cot; the procedure was done in the presence of the mother
Behavioral: Assess pain with the NIPS score
In group 1 (BF+SSC), neonates dressed with a diaper were held in prone, in SSC with the mother; BF was started at least 5 minutes before heel lance and maintained during sampling. In group 2 (sucrose + SSC), neonates were held in prone between the mothers' breast at least 5 minutes before sampling and 2 ml 24% sucrose was given with a sterile syringe in the mouth 2 minutes before heel lance. In group 3 (SSC), neonates were held between the mother's breast as in group 2, but no sucrose was given. In group 4 (Sucrose), 2 ml 24% sucrose was administered through a sterile syringe in the mouth 2 minutes before heel lance to neonates laid on supine on a cot; the procedure was done in the presence of the mother. Mothers were allowed to speak or touch their babies in all the groups.

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   37 Weeks to 41 Weeks
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy term neonates (37-41+6 weeks of gestation) confirmed through a routine physical exam during the first 24h of life
  • Wish to breastfeed
  • Absence of feeding during the previous 60 minutes.

Exclusion Criteria:

  • Maternal use of opioids.
  • Birth in general anesthesia.
  • Artificial feeding.
  • Previous capillar or venous sampling.
  • Previous admission to the neonatal unit.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01576432

Locations
Spain
Hospital Universitario Puerta de Hierro-Majadahonda
Madrid, Spain, 28220
Sponsors and Collaborators
Puerta de Hierro University Hospital
Investigators
Principal Investigator: Miguel A Marín Gabriel, MD Deparment of Pediatrics. Hospital Universitario Puerta de Hierro-Majadahonda. Madrid. Spain
  More Information

Publications:

Responsible Party: Miguel Angel Marin Gabriel, Medical Doctor, Pediatrician, Principal Investigator., Puerta de Hierro University Hospital
ClinicalTrials.gov Identifier: NCT01576432     History of Changes
Other Study ID Numbers: 260 271110
Study First Received: April 2, 2012
Last Updated: April 10, 2012
Health Authority: Spain: Ethics Committee

Keywords provided by Puerta de Hierro University Hospital:
Pain
Breastfeeding
Heel prick
Sucrose
Skin-to-skin contact
Newborn

ClinicalTrials.gov processed this record on September 14, 2014